Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC

Marcelo V. Negrão, Haniel A. Araújo, Giuseppe Lamberti, +63

Cancer Discovery

Change in neutrophil to lymphocyte ratio during immunotherapy treatment is a non-linear predictor of patient outcomes in advanced cancers

Mingjia Li, Daniel Spakowicz, Jarred Burkart, +11

Journal of Cancer Research and Clinical Oncology

Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medications

Daniel Spakowicz, Rebecca Hoyd, Mitchell Muniak, +17

BMC Cancer

Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium

Talal El Zarif, Amin H. Nassar, Elio Adib, +78

Journal of Clinical Oncology

Brief report: inhaled corticosteroid use and the risk of checkpoint inhibitor pneumonitis in patients with advanced cancer

Mingjia Li, Daniel Spakowicz, Songzhu Zhao, +13

Cancer Immunology Immunotherapy

Advanced CancerAdvanced Lung DiseaseMedicineBrief ReportPathology +5

Checkpoint inhibitor immunotherapy toxicity and overall survival among older adults with advanced cancer

Andrew Johns, Lai Wei, Madison Grogan, +14

Journal of Geriatric Oncology

Advanced CancerCancer ImmunosurveillanceOverall SurvivalMedicineImmunology +7

Serum Albumin: Early Prognostic Marker of Benefit for Immune Checkpoint Inhibitor Monotherapy But Not Chemoimmunotherapy

Yizhen Guo, Lai Wei, Sandip H. Patel, +19

Clinical Lung Cancer

Immune checkpoint inhibitor-related thrombocytopenia: incidence, risk factors and effect on survival

Tyler Haddad, Songzhu Zhao, Mingjia Li, +15

Cancer Immunology Immunotherapy

How Oestrogen or Progesterone might Change a woman's susceptibility to HIV‐1 infection

Mingjia Li, R. V. Short

Australian and New Zealand Journal of Obstetrics and Gynaecology

A multicenter study assessing survival in patients with metastatic renal cell carcinoma receiving immune checkpoint inhibitor therapy with and without cytoreductive nephrectomy

Evan Gross, Mingjia Li, Ming Yin, +24

Urologic Oncology Seminars and Original Investigations

Surgical OncologyUrologyGenitourinary CancerMedicineCytoreductive Nephrectomy +6